These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 20224065)
21. Polyfunctional CD4(+) and CD8(+) T cell responses to tuberculosis antigens in HIV-1-infected patients before and after anti-retroviral treatment. Sutherland JS; Young JM; Peterson KL; Sanneh B; Whittle HC; Rowland-Jones SL; Adegbola RA; Jaye A; Ota MO J Immunol; 2010 Jun; 184(11):6537-44. PubMed ID: 20435929 [TBL] [Abstract][Full Text] [Related]
22. Mycobacterium avium and purified protein derivative-specific cytotoxicity mediated by CD4+ lymphocytes from healthy HIV-seropositive and-seronegative individuals. Ravn P; Pedersen BK J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(5):433-41. PubMed ID: 8757419 [TBL] [Abstract][Full Text] [Related]
23. Bacille Calmette-Guérin Vaccine Strain Modulates the Ontogeny of Both Mycobacterial-Specific and Heterologous T Cell Immunity to Vaccination in Infants. Kiravu A; Osawe S; Happel AU; Nundalall T; Wendoh J; Beer S; Dontsa N; Alinde OB; Mohammed S; Datong P; Cameron DW; Rosenthal K; Abimiku A; Jaspan HB; Gray CM Front Immunol; 2019; 10():2307. PubMed ID: 31649662 [TBL] [Abstract][Full Text] [Related]
24. Intranasal immunization with peptide-based immunogenic complex enhances BCG vaccine efficacy in a murine model of tuberculosis. Kumar S; Bhaskar A; Patnaik G; Sharma C; Singh DK; Kaushik SR; Chaturvedi S; Das G; Dwivedi VP JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33444288 [TBL] [Abstract][Full Text] [Related]
26. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection. Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555 [TBL] [Abstract][Full Text] [Related]
27. Attrition of T-cell functions and simultaneous upregulation of inhibitory markers correspond with the waning of BCG-induced protection against tuberculosis in mice. Nandakumar S; Kannanganat S; Posey JE; Amara RR; Sable SB PLoS One; 2014; 9(11):e113951. PubMed ID: 25419982 [TBL] [Abstract][Full Text] [Related]
28. A CD4+ TNF+ monofunctional memory T-cell response to BCG vaccination is associated with Mycobacterium tuberculosis infection in infants exposed to HIV. Warr AJ; Anterasian C; Shah JA; De Rosa SC; Nguyen FK; Maleche-Obimbo E; Cranmer LM; Matemo D; Mecha J; Kinuthia J; LaCourse SM; John-Stewart GC; Hawn TR EBioMedicine; 2022 Jun; 80():104023. PubMed ID: 35533496 [TBL] [Abstract][Full Text] [Related]
30. A multiple T cell epitope comprising DNA vaccine boosts the protective efficacy of Bacillus Calmette-Guérin (BCG) against Mycobacterium tuberculosis. Maurya SK; Aqdas M; Das DK; Singh S; Nadeem S; Kaur G; Agrewala JN BMC Infect Dis; 2020 Sep; 20(1):677. PubMed ID: 32942991 [TBL] [Abstract][Full Text] [Related]
31. Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations. Sharpe S; White A; Sarfas C; Sibley L; Gleeson F; McIntyre A; Basaraba R; Clark S; Hall G; Rayner E; Williams A; Marsh PD; Dennis M Tuberculosis (Edinb); 2016 Dec; 101():174-190. PubMed ID: 27865390 [TBL] [Abstract][Full Text] [Related]
32. The impact of HIV exposure and maternal Mycobacterium tuberculosis infection on infant immune responses to bacille Calmette-Guérin vaccination. Jones CE; Hesseling AC; Tena-Coki NG; Scriba TJ; Chegou NN; Kidd M; Wilkinson RJ; Kampmann B AIDS; 2015 Jan; 29(2):155-65. PubMed ID: 25535752 [TBL] [Abstract][Full Text] [Related]
33. Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells. Scriba TJ; Tameris M; Mansoor N; Smit E; van der Merwe L; Isaacs F; Keyser A; Moyo S; Brittain N; Lawrie A; Gelderbloem S; Veldsman A; Hatherill M; Hawkridge A; Hill AV; Hussey GD; Mahomed H; McShane H; Hanekom WA Eur J Immunol; 2010 Jan; 40(1):279-90. PubMed ID: 20017188 [TBL] [Abstract][Full Text] [Related]
34. Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin for Infants of Human Immunodeficiency Virus-Infected Mothers: A Phase 2 Randomized, Controlled Trial. Nemes E; Hesseling AC; Tameris M; Mauff K; Downing K; Mulenga H; Rose P; van der Zalm M; Mbaba S; Van As D; Hanekom WA; Walzl G; Scriba TJ; McShane H; Hatherill M; Clin Infect Dis; 2018 Feb; 66(4):554-563. PubMed ID: 29028973 [TBL] [Abstract][Full Text] [Related]
35. Mycobacterium bovis BCG vaccination induces memory CD4+ T cells characterized by effector biomarker expression and anti-mycobacterial activity. Endsley JJ; Hogg A; Shell LJ; McAulay M; Coffey T; Howard C; Capinos Scherer CF; Waters WR; Nonnecke B; Estes DM; Villarreal-Ramos B Vaccine; 2007 Dec; 25(50):8384-94. PubMed ID: 17996992 [TBL] [Abstract][Full Text] [Related]
36. Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry. Kagina BM; Mansoor N; Kpamegan EP; Penn-Nicholson A; Nemes E; Smit E; Gelderbloem S; Soares AP; Abel B; Keyser A; Sidibana M; Hughes JE; Kaplan G; Hussey GD; Hanekom WA; Scriba TJ J Immunol Methods; 2015 Feb; 417():22-33. PubMed ID: 25523923 [TBL] [Abstract][Full Text] [Related]
37. The immune responses of central and effector memory BCG-specific CD4+ T cells in BCG-vaccinated PPD+ donors were modulated by Treg cells. Li L; Qiao D; Zhang X; Liu Z; Wu C Immunobiology; 2011 Apr; 216(4):477-84. PubMed ID: 20950889 [TBL] [Abstract][Full Text] [Related]
38. Immune profiling of Mycobacterium tuberculosis-specific T cells in recent and remote infection. Mpande CAM; Rozot V; Mosito B; Musvosvi M; Dintwe OB; Bilek N; Hatherill M; Scriba TJ; Nemes E; EBioMedicine; 2021 Feb; 64():103233. PubMed ID: 33610126 [TBL] [Abstract][Full Text] [Related]
39. CD4 and CD8 T cell responses to the M. tuberculosis Ag85B-TB10.4 promoted by adjuvanted subunit, adenovector or heterologous prime boost vaccination. Elvang T; Christensen JP; Billeskov R; Thi Kim Thanh Hoang T; Holst P; Thomsen AR; Andersen P; Dietrich J PLoS One; 2009; 4(4):e5139. PubMed ID: 19357780 [TBL] [Abstract][Full Text] [Related]